>> View All Results for ""
Enter multiple symbols separated by commas
London quotes now available
Bullish option traders are piling into Valeant Pharmaceuticals as its shares reach all-time highs.
As this seasons begins to draw to a close, Michael K. Farr argues that accounting gimmickry is no substitute for real earnings growth.
Get the best of CNBC in your inbox